Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Visa
V
|
+$1.8B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.68B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$715M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$669M |
Top Sells
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$878M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$534M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$471M |
| 4 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$344M |
| 5 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$325M |
Sector Composition
| 1 | Technology | 17.92% |
| 2 | Healthcare | 10.92% |
| 3 | Financials | 10.42% |
| 4 | Consumer Discretionary | 9.12% |
| 5 | Industrials | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Autohome
ATHM
$3.54B
| $7.57M | ﹤0.01% |
263,041
+1,678
| +0.6% | +$48.3K |
|
2302
Brinker International
EAT
$6.42B
| $7.54M | ﹤0.01% |
301,766
+130,319
| +76% | +$3.26M |
|
|
CDMO
2303
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $7.53M | ﹤0.01% |
394,005
+44,069
| +13% | +$843K |
|
2304
Herbalife
HLF
$960M
| $7.52M | ﹤0.01% |
378,209
-75,536
| -17% | -$1.5M |
|
2305
ScottsMiracle-Gro
SMG
$3.46B
| $7.51M | ﹤0.01% |
175,671
+77,003
| +78% | +$3.29M |
|
2306
International Seaways
INSW
$2.42B
| $7.51M | ﹤0.01% |
213,744
-9,649
| -4% | -$339K |
|
2307
Supernus Pharmaceuticals
SUPN
$2.51B
| $7.51M | ﹤0.01% |
221,732
-85,751
| -28% | -$2.9M |
|
2308
Palomar
PLMR
$3.08B
| $7.51M | ﹤0.01% |
89,638
-44,068
| -33% | -$3.69M |
|
2309
Griffon
GFF
$3.53B
| $7.5M | ﹤0.01% |
254,164
+30,732
| +14% | +$907K |
|
|
QFTA
2310
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
| $7.49M | ﹤0.01% |
760,000
| – | – |
|
2311
Construction Partners
ROAD
$7.07B
| $7.48M | ﹤0.01% |
285,187
+103,985
| +57% | +$2.73M |
|
2312
First Trust Lunt US Factor Rotation ETF
FCTR
$59.3M
| $7.47M | ﹤0.01% |
285,394
+197,294
| +224% | +$5.16M |
|
2313
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $7.42M | ﹤0.01% |
772,222
+171,247
| +28% | +$1.65M |
|
|
HCP
2314
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $7.42M | ﹤0.01% |
+230,513
| New | +$7.42M |
|
|
SOVO
2315
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $7.41M | ﹤0.01% |
520,661
-15,527
| -3% | -$221K |
|
2316
W&T Offshore
WTI
$268M
| $7.41M | ﹤0.01% |
1,264,964
+372,544
| +42% | +$2.18M |
|
2317
Karyopharm Therapeutics
KPTI
$52.7M
| $7.4M | ﹤0.01% |
90,345
-6,082
| -6% | -$498K |
|
|
JMIA
2318
Jumia Technologies
JMIA
$1.45B
| $7.39M | ﹤0.01% |
1,271,525
+418,088
| +49% | +$2.43M |
|
2319
Hillenbrand
HI
$1.7B
| $7.37M | ﹤0.01% |
200,578
-777,528
| -79% | -$28.5M |
|
2320
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.07B
| $7.36M | ﹤0.01% |
280,757
-58,701
| -17% | -$1.54M |
|
2321
First Trust NASDAQ-100 Equal Weighted Index Fund
QQEW
$1.88B
| $7.36M | ﹤0.01% |
87,911
+64,023
| +268% | +$5.36M |
|
2322
Provident Financial Services
PFS
$2.58B
| $7.35M | ﹤0.01% |
376,705
+109,374
| +41% | +$2.13M |
|
|
ENPC
2323
DELISTED
Executive Network Partnering Corporation
ENPC
| $7.34M | ﹤0.01% |
735,696
-5,400
| -0.7% | -$53.9K |
|
2324
Harmony Biosciences
HRMY
$1.84B
| $7.34M | ﹤0.01% |
165,611
+97,334
| +143% | +$4.31M |
|
2325
Kymera Therapeutics
KYMR
$3.44B
| $7.33M | ﹤0.01% |
336,759
+59,495
| +21% | +$1.3M |
|